Overview

Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer

Status:
Terminated

Trial end date:
2013-02-01

Target enrollment:

Participant gender:

Summary

This phase II trial will study the effectiveness and toxicity of sequential high dose MVAC followed by gemcitabine and cisplatin, as first line treatment in patients with locally advanced or metastatic bladder cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Hellenic Oncology Research Group

Collaborator:

University Hospital of Crete

Treatments:

Cisplatin
Doxorubicin
Gemcitabine
Liposomal doxorubicin
Methotrexate
Vinblastine